News + Insights
All News +Insights- Behind Every Parkinson’s Researcher, There’s a Story
Ariella Bersan
- Target Product Profile: Key to Success in Drug Development
Danielle Gerhard, PhD
- SPARK NS and Haukeland Univ Hospital Begin Parkinson's Clinical Trial
Susan Thomas
- Now Open: SPARK NS Call for Proposals, 2027 Cohort
Ariella Bersan - Starting with the End in Mind
Opher Kornfeld, PhD - What Surprised an Academic About Drug Development
Daria Mochly-Rosen, PhD - What Comes After Levodopa?
Danielle Gerhard, PhD
Spotlight
Miratul Muqit, MBChB, PhD: A Study In PINK
Parkinson’s researcher pursues therapies that can prevent the loss of brain cells that will slow or stop the progression of the disease.
Spotlight
Get Involved
Call for Proposals
SPARK NS is accepting applications for the SPARK NS Translational Research Program, 2027 Cohort. Principal investigators developing therapeutics for autism and Parkinson's disease in the United States, Canada, the United Kingdom, and Europe are invited to apply.
Explore the SPARK NS Translational Research Program
The funding and high-level of support provided by our program helps ensure that each project selected for participation meets its translational objectives and continues on the path to market.
Sign Up for Updates
Sign up for updates about SPARK NS, our program, projects, and other opportunities.